We’re a boutique, full-service CRO operating globally with lean teams and high-value assets. We take a hands-on approach, delivering flexible engagement models, ensuring complete pricing transparency, and taking ownership of projects – without adding unnecessary overhead.
With hundreds of trials delivered, we focus on therapeutic areas where innovation is most needed, including oncology, cardiology, and rare diseases, with a particular emphasis on nuclear medicine. We offer an Integrated Digital Clinical Trial Solution, delivering flexible engagement models tailored to your needs with maximum transparency, scalability, and cost efficiency.
Our promise? Faster, smarter, leaner clinical trials – without compromise. Axcellant in every aspect.
years of experience
clients
trials delivered
sites supported
patients enrolled
Our senior team remains closely involved in the whole process – from strategy and protocol design through execution and readout, ensuring patient impact stays at the core while minimizing amendments and accelerating study start-up.
We combine deep scientific expertise with purpose-built digital tools and a modular platform that adapts to each study. This sharpens feasibility, site and patient selection, and monitoring, while providing real-time visibility into enrollment, safety, and operational KPIs—no chasing updates. The result is right-first-time execution and submission-ready packages for FDA and EMA—smarter, safer, more adaptable trials that deliver investor-grade evidence.
Our regulatory team specializes in crafting effective regulatory strategies and ensuring compliance throughout the project lifecycle. From initial planning to completion, we provide expert guidance to navigate complex regulatory frameworks with precision and efficiency.
Over the years we have supported organisations across many therapeutic areas, from various medicinal products phase I or medical devices pilot programmes through to very niche esoteric clinical packages of activity.
Our passion for science, an unwavering commitment to improve the lives of patients and an unflagging energy to deliver on commitments has enabled us to gain broad expertise.
How Axcellant stabilized isotope supply, synchronized global imaging operations, and prevented a multi-month program delay. At a Glance Study type:…
At Axcellant, we work where medtech becomes real, not in headlines but in clinics, documentation, and decisions that must stand…
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
Copyright @ 2026 Axcellant